1 Supplementary Figure S1. Developmental PSs belonging to nervous system development. Stem cells were randomly differentiated for 14 days or specifically.

Slides:



Advertisements
Similar presentations
DNA microarray technology allows an individual to rapidly and quantitatively measure the expression levels of thousands of genes in a biological sample.
Advertisements

Supplementary Figure S1 eQTL prior model modified from previous approaches to Bayesian gene regulatory network modeling. Detailed description is provided.
Log 2 (expression) H3K4me2 score A SLAMF6 log 2 (expression) Supplementary Fig. 1. H3K4me2 profiles vary significantly between loci of genes expressed.
Getting the story – biological model based on microarray data Once the differentially expressed genes are identified (sometimes hundreds of them), we need.
Supplementary Figure 1 List of top 50 most abundantly expressed lncRNAs and mRNAs in HP and PFC from RNAseq. Expression abundance of lncRNAs and mRNAs.
Volume 3, Issue 6, Pages (December 2014)
M. Fu, G. Huang, Z. Zhang, J. Liu, Z. Zhang, Z. Huang, B. Yu, F. Meng 
Volume 2, Issue 2, Pages (February 2016)
Volume 21, Issue 11, Pages (December 2017)
Strategy Description Discovery Validation Application
Sensitivity of RNA‐seq.
Volume 20, Issue 13, Pages (September 2017)
Volume 33, Issue 1, Pages (July 2010)
Volume 11, Issue 2, Pages (August 2012)
Volume 8, Issue 4, Pages (April 2011)
Volume 17, Issue 11, Pages (December 2016)
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Volume 16, Issue 1, Pages (January 2015)
Volume 29, Issue 1, Pages (April 2014)
Volume 9, Issue 3, Pages (September 2017)
Genetic and Epigenetic Determinants of Neurogenesis and Myogenesis
Volume 63, Issue 4, Pages (October 2015)
Zhifei Luo, Suhn Kyong Rhie, Fides D. Lay, Peggy J. Farnham 
Revealing Global Regulatory Perturbations across Human Cancers
CellNet: Network Biology Applied to Stem Cell Engineering
Genome-wide Transcriptome Profiling Reveals the Functional Impact of Rare De Novo and Recurrent CNVs in Autism Spectrum Disorders  Rui Luo, Stephan J.
Transcriptional Landscape of Cardiomyocyte Maturation
Volume 67, Issue 6, Pages e6 (September 2017)
Molecular Therapy - Methods & Clinical Development
Volume 33, Issue 4, Pages e6 (April 2018)
Volume 3, Issue 1, Pages (July 2016)
Volume 9, Issue 3, Pages (September 2017)
Transcriptional Profiling of Quiescent Muscle Stem Cells In Vivo
Volume 48, Issue 5, Pages (December 2012)
Volume 7, Issue 3, Pages (September 2016)
Compartment‐specific analysis reveals differences in organelle composition that can be validated by sub‐cellular fractionation Compartment‐specific analysis.
Volume 21, Issue 11, Pages (December 2017)
Volume 63, Issue 4, Pages (August 2016)
Taming Human Genetic Variability: Transcriptomic Meta-Analysis Guides the Experimental Design and Interpretation of iPSC-Based Disease Modeling  Pierre-Luc.
Revealing Global Regulatory Perturbations across Human Cancers
Volume 21, Issue 3, Pages e7 (September 2017)
Michal Levin, Tamar Hashimshony, Florian Wagner, Itai Yanai 
RUNX1 and the endothelial origin of blood
Volume 19, Issue 2, Pages (August 2016)
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Neurogenins induce a network of transcription factors that mediate iNGN neurogenesisA network of transcription factors involved in iNGN neurogenesis was.
Volume 9, Issue 4, Pages (October 2011)
Volume 14, Issue 6, Pages (June 2014)
Volume 9, Issue 5, Pages (November 2017)
Gene expression profiling of human bone marrow-derived mesenchymal stem cells during adipogenesis DOI: /FHC.a Gene-act-network according.
Volume 42, Issue 5, Pages e7 (September 2017)
Volume 8, Issue 4, Pages (April 2011)
Varying Intolerance of Gene Pathways to Mutational Classes Explain Genetic Convergence across Neuropsychiatric Disorders  Shahar Shohat, Eyal Ben-David,
Volume 3, Issue 6, Pages (December 2014)
Volume 122, Issue 6, Pages (September 2005)
Volume 11, Issue 1, Pages (July 2018)
Volume 10, Issue 4, Pages (April 2018)
Volume 14, Issue 6, Pages (June 2014)
A multitiered approach to characterize transcriptome structure.
Volume 16, Issue 2, Pages (February 2015)
Characterising dermis expansion and gene expression changes during mouse development (related to Fig 1)‏ Characterising dermis expansion and gene expression.
Functional classification and visualization of differentially expressed genes. Functional classification and visualization of differentially expressed.
Lab-Specific Gene Expression Signatures in Pluripotent Stem Cells
CD4+CLA+CD103+ T cells from human blood and skin share a transcriptional profile. CD4+CLA+CD103+ T cells from human blood and skin share a transcriptional.
The CREBBP-modulated network is enriched in signaling pathways upregulated in the light zone (LZ). The CREBBP-modulated network is enriched in signaling.
Nanog-Independent Reprogramming to iPSCs with Canonical Factors
Transcriptomic changes in strains PAK and PAKpmrB6 in response to polymyxin B (PMB). Transcriptomic changes in strains PAK and PAKpmrB6 in response to.
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Volume 27, Issue 7, Pages e4 (May 2019)
Characteristic gene expression patterns distinguish LCH cells from other immune cells present in LCH lesions. Characteristic gene expression patterns distinguish.
Presentation transcript:

1 Supplementary Figure S1. Developmental PSs belonging to nervous system development. Stem cells were randomly differentiated for 14 days or specifically differentiated towards neuroectodermal progenitor cells for 6 days. Transcriptome profiles were obtained for day 0 and day 14 (UKK) or day 6 (UKN1) of differentiation. Genes belonging to the nervous system development (fold change ≥ ±2, FDR-corrected p value <0.05) were identified and are represented in the figure.

2 Supplementary Figure S2. Tissue classification based on CellNet analysis. Embryonic stem cell (ESC) and tissue classification probability for day 0 and day of differentiation (6 or 14) was obtained by CellNet analysis. Although the tissue classification scores were <0.1, they nevertheless revealed an increase during differentiation (day 14 or day 6) compared with those at day 0. In addition, higher tissue classification scores for neuron, lung, and heart tissue were found in the UKK system compared with those of the UKN1 system.

-2.6 to to to UKK: compounds deregulated PSs UKN1: developmental PSs UKN1: compounds deregulated PSs B C D -3.7 to 9 Supplementary Figure S3. Frequency distribution plots of deregulated probe sets (PSs). Numbers of all deregulated PSs were plotted as the frequency in 100 bins obtained with equal distribution from the maximum to minimum fold change values. (A) For UKK developmental genes, 100 bins are constituted with fold change values ranging from to The majority of developmental genes fall into the bins with fold change values ranging from -3.7 to +9. (B) For UKN1 developmental genes, 100 bins are constituted with fold changes values ranging from to The majority of developmental genes fall in the bins with fold change values ranging from -7.4 to +13. (C) For mercurial- and HDACi-deregulated genes in the UKK system, 100 bins are constituted with fold changes values ranging from to The majority of these fall into the bins with fold change values ranging from -2.1 to (D) For mercurial- and HDACi-deregulated genes in the UKN1 system, 100 bins are constituted with fold changes values ranging from to Most genes fall into the bins with fold change values ranging from -2.6 to UKK: developmental PSs A

4 A B Down-reg. D-genes with absolute numbers Up-reg. D-genes with absolute numbers. * The numbers on the X-axis (2;5;10) represents the fold change values of D-genes. Supplementary Figure S4. Overlap analysis of developmental genes and unified genes influenced by mercurials and HDACis. Differentiating cells were treated by mercurials and HDACis, as indicated in Fig. 1A, and were used for transcriptome analysis. Genes affected by the differentiation process (D-genes) were identified as described in Suppl. Table 1, and toxicant-affected genes (T-genes) were identified as described in Fig. 4. (A) The overlap of up- regulated mercurial T-genes with up- (red) and down- (blue) regulated D-genes as well as the overlap of down-regulated mercurial T-genes with up- and down-regulated D-genes was calculated for each system. The data are expressed as the fraction of D-genes affected by toxicants. (B) The same procedure was performed for the HDACis. Blue bars represent D- genes down-regulated and red bars indicate D-genes up-regulated during normal differentiation. The numbers on top of the bars indicate the absolute number of PSs affected.

5 AB CD Supplementary Figure S5. Overlap analysis of baseline expression values (log2 scale) of developmental genes and unified genes influenced by mercurials and HDACis. The developmental genes were subcategorised based on baseline expression values (log2 scale) in the four groups i) day 0 >6, day 6 or 14 6; iii) day 0 6, day 6 or 14 >6. These groups were further overlapped with unified genes for mercurials and HDACis and plotted for visualization as percent overlap vs baseline expression groups. (A) The percent influence of developmental genes in the groups i and ii with mercurials was higher in the UKN1 test system and appears to be more sensitive compared with the UKK test system. (B) The percent influence of developmental genes in groups i and ii with HDACis was also higher in the UKN1 test system, but both systems appear to be sensitive to HDACis. (C, D) The numbers of all PSs belonging to untreated controls in the UKK and UKN1 test systems were plotted as frequencies in 100 bins obtained with equal distribution from the maximum to minimum fold change values. Frequency vs bins plots were obtained and are graphically represented in the figures.

A 6 C D EF D-genes: for specific developments in UKN1 as follows : Neurogenesis: 419 Axonogenesis : 139 NC differentiation : 31 Neural tube formation : 31 Sensory organ dev. : 147 Telencephalon dev. : 81 T-genes : see bars (B,D;F); O-genes: see bars (A;C,E) D-genes: for specific developments in UKK as follows : Nervous syst. dev.: 689 Heart dev. : 130 Sensory organ dev. : 144 Skin dev. : 27 Limb dev. : 94 Liver dev. : 40 Fisher's exact test *<0.05 **<0.01 ***<0.001 Supplementary Figure S6. Characterization of toxicants based on developmental index and potency as a measure for specific developmental toxicity. The list of specific developmental PSs belonging to gene ontology categories (nervous system development, sensory organ, limb, heart, skin and liver development in the UKK test system; neurogenesis, neural tube formation, axonogenesis, neural crest cell differentiation, telencephalon and sensory organ development in the UKN1 test system) was obtained by uploading developmental genes into the online tool `DAVID´. The developmental potency (D p ) and developmental index (D i ) values were obtained as per the formula in Fig. 7A. (A, B) D p and D i for thalidomide in the UKK test system. (C, D) D p and D i for mercurials and HDACis in the UKK test system. (E, F) D p and D i for mercurials and HDACis in the UKN1 test system. B

7 Supplementary Figure S7. TF networks in the UKK and UKN1 systems. Human stem cells were differentiated and treated as shown in Fig. 1A, and toxicant consensus genes were identified from the transcriptome data as described in Fig. 4. Then, a generic human TF network was designed as described in Fig. 5C. The TFs that are found both amongst UKK (top) and UKN1 (bottom) D-genes (regulated by ≥ ±5-fold, p <0.05) were selected and highlighted in the TF networks (red: up-regulation; blue: down- regulation). MECOM TBX3 TFAP2A HOXB8 HOXA2 HOXA5 HOXA3 FOXF1 PRRX1 ZNF25 EBF1 NFIA ZFPM2 SNAI2 LEP1 HOXC6 HOXB6 UKK specific UKK mapping Cut off: Fold change > 5; p < 0:05 UKN1 specific UKN1 mapping